| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1106/J00T-W7M9-C18C-Q6Y6 Reducing Pulmonary Disease: The Pharmacists Role in Smoking CessationSchool of Pharmacy, University of California, San Francisco, 521 Parnassus Avenue, Room C152, San Francisco, CA 94143-0622
School of Pharmacy, University of California, San Francisco, 521 Parnassus Avenue, Room C152, San Francisco, CA 94143-0622
School of Pharmacy, University of California, San Francisco, 521 Parnassus Avenue, Room C152, San Francisco, CA 94143-0622
California State Board of Pharmacy, Department of Consumer Affairs, 400 R. Street, Suite 4070, Sacramento, CA 95814-6200
The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 243, Houston, TX 77030 As an important interface with the healthcare system for many patients, pharmacists are in a unique position to assist patients with quitting smoking, thereby improving patients pulmonary health. Because nicotine replacement therapy products and bupropion are available to patients largely via pharmacies, the pharmacist has become a logical candidate for providing smoking cessation assistance. Furthermore, research has shown that when pharmacists counsel patients on medications for quitting smoking, their intervention positively impacts smoking cessation rates. This article provides a review of methods for cessation and provides pharmacists with feasible and effective smoking cessation counseling strategies for implementation into everyday practice. The intervention approach draws heavily upon the U.S. Public Health Service Clinical Practice Guideline for Treating Tobacco Use and Dependence.
Key Words: smoking cessation pharmacist pulmonary disease
|